Membership

Endocrine Cancers SIG

March 10, 2023

Discuss advancements in understanding and treating endocrine cancers and collaborate with colleagues on the best avenues for care. By becoming a member of the Endocrine Cancers SIG, you will be the first to know about the SIG’s educational content and networking activities. Sign up today! Engage with your peers in the SIG subgroup in the EndoForum online community in DocMatter. 

View the Endocrine Cancers leadership roster. 

Endocrine Cancers SIG Past Webinars

Date: January 16, 2024

Time: 11:00 AM - 12:30 PM ET

Moderator: Daniel E. Frigo (Professor; University of Texas MD Anderson Cancer Center)

Speakers:

  • Peter S. Nelson, MD (Stuart and Molly Sloan Precision Oncology Institute Endowed Chair and Professor, Divisions of Human Biology and Clinical Research, Director of Prostate Cancer Research, Fred Hutchinson Cancer Center)
  • Gerhardt Attard, MD, PhD, FRCP (John Black Charitable Foundation Endowed Chair in Urological Cancer Research at University College London; Team Leader of the Treatment Resistance Group at the UCL Cancer Institute)
  • Ciara Metcalfe, PhD (Senior Principal Scientist, Translational Oncology, Genentech/Roche)

Description:

In this webinar we will discuss resistance to androgen receptor (AR)-targeted therapy in prostate cancer, the various molecular mechanisms through which AR activity is restored after therapy, and new treatment approaches involving next-generation AR-targeting agents and/or combination therapies.

Learning Objectives:

  • Learn mechanisms of androgen receptor reactivation following initial androgen receptor signaling inhibition.
  • Understand how various androgen receptor signaling inhibitors work and when they are used in patients.
  • Understand what other treatment modalities are being combined with androgen receptor signaling inhibitors to treat patients.
  • Learn new methods being developed to target androgen receptor signaling more effectively.

Causes, Diagnosis, and Treatment of Parathyroid Cancer

September 1, 2022

Faculty:
 Maria Luisa Brandi, MD, PhD
Professor of Endocrinology
University of Florence

Case Presenter:
Briana Cortez
MD/MPH Student
University of Texas Rio Grande Valley School of Medicine

Moderator:
Sunita Agarwal, PhD
Staff Scientist
NIDDK, NIH

Learning Objectives:

  • Understand the pathogenesis and genetic pathways of parathyroid cancer.
  • Recognize the symptoms of diagnostic process for parathyroid cancer.
  • Gain an update on the surgical and pharmacological management of the disease, including the newest treatment options. 

View Recording

Endocrine Cancers SIG held an April 27, 2022 webinar on the diagnosis, surgical management, and latest therapies for anaplastic thyroid cancer.

Learning Objectives

  • 1. Describe the important tests for diagnosing and staging anaplastic thyroid cancer.

  • 2. Identify important factors for the optimal surgical management of anaplastic thyroid cancer.

  • 3. Describe evidence-based therapies for anaplastic thyroid cancer.

Speakers:

  • Electron Kebebew, MD, FACS, Harry A. Oberhelman Jr and Mark L. Welton Professor and Chief of General Surgery, Stanford University Health

  • Maria Cabanillas, MD, Oncologic Endocrinologist University of Texas MD Anderson Cancer Center

Moderators:

  • Zeina Hannoush, MD Assistant Clinical Professor University of Miami Health System

  • Samira Sadowski, MD Physician-Scientist Early Investigator National Cancer Institute, Center for Cancer Research

Medullary Thyroid Cancer webinar was held February 3, 2023. Learning Objectives:

  1. Learn how to avoid the pitfalls in pre-operative diagnosis of medullary thyroid cancer. 
  2. Discuss the current landscape of systemic therapy in advanced medullary thyroid cancer. 
  3. Explore neo-adjuvant therapy in the setting of advanced medullary thyroid cancer.

Speakers:

Mimi I. Hu, MD
Professor
The University of Texas MD Anderson Cancer Center

Gregory Randolph, MD, FACS, FACE
Professor of Otolaryngology–Head and Neck Surgery
Claire and John Bertucci Endowed Chair in Thyroid Surgical Oncology
Harvard Medical School
Director, Thyroid and Parathyroid Endocrine Surgical Division
Massachusetts Eye and Ear 

Case Presenters: 

Anupam Kotwol, MD
Assistant Professor, Division of Diabetes, Endocrinology, and Metabolism 
UNMC Nebraska Medicine 

Trisha Cubb, MD
Endocrinologist
Houston Methodist Hospital 
Assistant Professor of Clinical Medicine
Academic Institute at Houston Methodist Hospital 
Weill Cornell Medical College

View Recording

Adrenocortical Carcinoma: The Latest Pre-Clinical and Clinical Updates

Friday, February 17, 2023, 11:00 AM-12 PM EST 

Learning Objectives

  1. Review the essential clinical features of adrenocortical carcinoma (ACC)
  2. Discuss the translational research in ACC 
  3. Summarize treatment options for localized and advanced ACC

Speakers:

Mouhammed Habra, Md, FACP, FACE 
Professor 
Chief, Section of Endocrine Neoplasia
Department of Endocrine Neoplasia and Hormonal Disorders 
The University of Texas MD Anderson Cancer Center

Katja Kiseljak-Vassiliades, DO 
Associate Professor 
University of Colorado School of Medicine
Anschutz Medical Campus
Department of Internal Medicine
Division of Endocrinology, Metabolism and Diabetes

Moderator:

Inga Harbuz Miller, MD
Assistant Professor
University of Rochester 

View Recording

 

Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.